Management of thrombotic microangiopathy after hematopoietic cell transplantation: A position statement of ThREG (Turkish Hematology Research and Education Group)

dc.contributor.authorKaya, Ali Hakan
dc.contributor.authorTekgunduza, Emre
dc.date.accessioned2024-07-12T21:40:50Z
dc.date.available2024-07-12T21:40:50Z
dc.date.issued2021en_US
dc.department[Belirlenecek]en_US
dc.description.abstractHematopoietic stem cell transplantation associated-thrombotic microangiopathy (TA-HCT) is one of the early complications of endothelial origin in the course of HCT. Endothelial damage to the microvascular structure and the platelet-rich microthrombi, which are formed as a result of accompanying complement activation, constitute the main pathological conditions resulting TA-TMA. Early diagnosis and management are of utmost importance to prevent multi-organ failure and death. This review summarizes the current understanding of TA-TMA regarding pathogenesis, definition, differential diagnosis, risk factors, surveillance for early diagnosis and management.en_US
dc.identifier.doi10.1016/j.transci.2021.103313
dc.identifier.issn1473-0502
dc.identifier.issn1878-1683
dc.identifier.issue6en_US
dc.identifier.pmid34785151en_US
dc.identifier.scopus2-s2.0-85119302572en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.urihttps://doi.org/10.1016/j.transci.2021.103313
dc.identifier.urihttps://hdl.handle.net/20.500.12415/7503
dc.identifier.volume60en_US
dc.identifier.wosWOS:000733239700043en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherPergamon-Elsevier Science Ltden_US
dc.relation.ispartofTransfusion And Apheresis Scienceen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKY08865
dc.subjectHematopoietic Stem Cell Transplantationen_US
dc.subjectThrombotic Microangiopathyen_US
dc.subjectThrombocytopeniaen_US
dc.titleManagement of thrombotic microangiopathy after hematopoietic cell transplantation: A position statement of ThREG (Turkish Hematology Research and Education Group)en_US
dc.typeEditorial
dspace.entity.typePublication

Dosyalar